Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa
File(s)AIDS-D-16-00894_R2 (1).pdf (2.36 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Objective: To estimate time from HIV infection to linkage-to-care and its determinants.
Linkage-to-care is usually assessed using the date of HIV diagnosis as the starting
point for exposure time. However, timing of diagnosis is likely endogenous to linkage,
leading to bias in linkage estimation.
Design: We used longitudinal serosurveys from a large population-based HIV cohort in
KwaZulu-Natal (2004-2013) to estimate time of HIV infection. We linked this data to
patient records from a public-sector HIV treatment and care program to determine time
from infection to linkage (defined using the date of the first CD4 count).
Methods: We used Cox proportional-hazards models to estimate time from infection to
linkage and the effects of the following covariates on this time: gender, age, education,
food security, socio-economic status, area of residence, distance to clinics, knowledge
of HIV status, and whether other household members have initiated ART.
Results: We estimated that it would take an average of 4.9 years for 50% of
seroconverters to be linked to care (95% confidence intervals (CI): 4.2-5.7). Among all
cohort members that were linked to care, the median CD4 count at linkage was 350
cells/μL (95%CI: 330-380). Men and participants <30 years were found to have the
slowest rates of linkage-to-care. Time to linkage became shorter over calendar time.
Conclusions: Average time from HIV infection to linkage-to-care is long and needs to
be reduced to ensure that HIV treatment-as-prevention policies are effective. Targeted
interventions for men and young individuals have the largest potential to improve linkage rates
Linkage-to-care is usually assessed using the date of HIV diagnosis as the starting
point for exposure time. However, timing of diagnosis is likely endogenous to linkage,
leading to bias in linkage estimation.
Design: We used longitudinal serosurveys from a large population-based HIV cohort in
KwaZulu-Natal (2004-2013) to estimate time of HIV infection. We linked this data to
patient records from a public-sector HIV treatment and care program to determine time
from infection to linkage (defined using the date of the first CD4 count).
Methods: We used Cox proportional-hazards models to estimate time from infection to
linkage and the effects of the following covariates on this time: gender, age, education,
food security, socio-economic status, area of residence, distance to clinics, knowledge
of HIV status, and whether other household members have initiated ART.
Results: We estimated that it would take an average of 4.9 years for 50% of
seroconverters to be linked to care (95% confidence intervals (CI): 4.2-5.7). Among all
cohort members that were linked to care, the median CD4 count at linkage was 350
cells/μL (95%CI: 330-380). Men and participants <30 years were found to have the
slowest rates of linkage-to-care. Time to linkage became shorter over calendar time.
Conclusions: Average time from HIV infection to linkage-to-care is long and needs to
be reduced to ensure that HIV treatment-as-prevention policies are effective. Targeted
interventions for men and young individuals have the largest potential to improve linkage rates
Date Issued
2017-04-24
Date Acceptance
2017-01-24
Citation
AIDS, 2017, 31 (7), pp.1017-1024
ISSN
0269-9370
Publisher
Lippincott Williams & Wilkins
Start Page
1017
End Page
1024
Journal / Book Title
AIDS
Volume
31
Issue
7
Copyright Statement
This is the accepted version of the article. The final, published version can be found at Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa
Maheu-Giroux, Mathieu; Tanser, Frank; Boily, Marie-Claude; Pillay, Deenan; Joseph, Serene A.; Bärnighausen, Till. AIDS: 24 April 2017 - Volume 31 - Issue 7 - p 1017–1024
doi: 10.1097/QAD.0000000000001435
Maheu-Giroux, Mathieu; Tanser, Frank; Boily, Marie-Claude; Pillay, Deenan; Joseph, Serene A.; Bärnighausen, Till. AIDS: 24 April 2017 - Volume 31 - Issue 7 - p 1017–1024
doi: 10.1097/QAD.0000000000001435
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Virology
care continuum
CD4(+) cell count
HIV/AIDS
linkage-to-care
sex
treatment cascade
treatment-as-prevention
ANTIRETROVIRAL TREATMENT PROGRAM
PROSPECTIVE COHORT
SCALE-UP
THERAPY
INITIATION
MORTALITY
ART
PROFILE
DURBAN
INCOME
06 Biological Sciences
11 Medical And Health Sciences
17 Psychology And Cognitive Sciences
Publication Status
Published